BioInformatics, a BroadOak portfolio company, acquires Kalorama Information, a leading market research publisher focused on the in vitro diagnostics, biotechnology, healthcare, medical device, and pharmaceutical markets. The full press release is below. BioInformatics Inc. Acquires Kalorama Information, Further Solidifying a Leadership Position in the Life Science, Diagnostics,...
BroadOak Partners advises DANI Instruments (“DANI”) on its sale to PerkinElmer. DANI is a provider of advanced gas chromatography instruments and systems for food analysis, pharmaceutical, and environmental applications. The full story is below. PerkinElmer Revenues Grow 22 Percent, Diagnostics Up 59 Percent NEW YORK (GenomeWeb) – PerkinElmer...
Distributed Bio, a BroadOak portfolio company, provided Charles River Laboratories’ clients access to Distributed Bio’s antibody libraries and integrated antibody optimization technologies. Distributed Bio is a provider of antibody discovery, engineering, informatics tools, and services for the life sciences research and drug discovery markets. The full press...
BroadOak Partners advises LifeSpan Biosciences (“LSBio”) on the sale of the company to Thompson Street Capital Partners. LSBio provides antibodies and life science reagents to the academic and pharmaceutical research markets through its proprietary e-commerce platform. The full press release is below. Thompson Street Capital Partners Acquires...
BroadOak-backed Astero Bio, a leading developer of biologics cryopreservation solutions, acquires key assets and rights related to MedCision, LLC’s ThawSTAR cell thawing system and BioT cold storage and transport solutions. The full press release is below. Astero Bio Acquires Key Technologies for the Management of Cryopreserved Biologics...
BioInformatics, a BroadOak portfolio company, acquired IMV Publishing, a leading market research and online publishing business focused on the medical imaging and clinical diagnostic instruments markets. The full story is below. BioInformatics Inc. Acquires IMV Publishing March 13, 2018: BioInformatics Inc., the leading market research firm supporting the...
BroadOak Partners advises Lucigen Corporation on the sale of the company to LGC Limited. Lucigen is a leading provider of molecular biology enzymes, reagents, and kits for high growth applications in clinical diagnostics, drug discovery, synthetic biology, and gene editing. The full press release is below. LGC...
Stay connected
Partner with BroadOak